Title:
OPIOID SUSTAINED-RELEASED FORMULATION
Document Type and Number:
WIPO Patent Application WO2001008661
Kind Code:
A3
Abstract:
A solid, oral, controlled release dosage form comprising a therapeutically effective amount of an opioid compound, or a salt thereof, a matrix-forming polymer and an ionic exchange resin.
Inventors:
MALONEY ANN M
Application Number:
PCT/US2000/020413
Publication Date:
March 22, 2001
Filing Date:
July 27, 2000
Export Citation:
Assignee:
ROXANE LAB INC (US)
International Classes:
A61K9/20; A61K9/22; A61K9/26; C07D489/08; A61K9/28; A61K31/135; A61K31/216; A61K31/439; A61K31/451; A61K31/485; A61K47/30; A61K47/32; A61K47/34; A61K47/38; A61K47/48; A61P25/04; (IPC1-7): A61K9/20; A61K47/48; A61K31/485
Foreign References:
| US4859461A | 1989-08-22 | |||
| GB2176999A | 1987-01-14 | |||
| US5709882A | 1998-01-20 |
Other References:
SRIWONGJANYA M ET AL: "EFFECT OF ION EXCHANGE RESINS ON THE DRUG RELEASE FROM MATRIX TABLETS", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS,NL,ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, vol. 46, no. 3, 1 November 1998 (1998-11-01), pages 321 - 327, XP000787137, ISSN: 0939-6411
Download PDF:
Previous Patent: TARGETED FIBERLESS RADIATIVE EFFECTORS
Next Patent: LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL
Next Patent: LIQUID PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL